Medicare Enrolled
Dr. Michael Radonich, M.D.
Optician · Los Alamitos, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Radonich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Radonich?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Radonich
Dr. Michael Radonich is an optician specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Radonich performed 10,603 Medicare services across 3,417 unique beneficiaries.
Between the years covered by Open Payments, Dr. Radonich received a total of $1,686 from 14 pharmaceutical and/or device companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Radonich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in CA
$1,686 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,603
Medicare services
Top 8% in CA for optician
3,417
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~558 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
3,271 | $63 | $85 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,836 | $6 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
904 | $71 | $96 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 601 | $106 | $144 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
577 | $101 | $142 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
512 | $142 | $193 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals. |
463 | $82 | $112 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
386 | $31 | $62 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
346 | $97 | $134 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
298 | $149 | $195 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
269 | $62 | $114 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
251 | $74 | $108 |
| Destruction of small cancerous skin growth on face or mouth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 centimeters or less located on the face, ears, eyelids, nose, lips, or mouth. |
181 | $68 | $97 |
| Destruction of small cancerous skin growth This procedure involves the removal or destruction of a cancerous skin lesion measuring 0.5 cm or less on the scalp, neck, hands, feet, or genitals. |
92 | $69 | $99 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
65 | $1 | $5 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
63 | $60 | $86 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
54 | $60 | $87 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
42 | $31 | $65 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
40 | $66 | $113 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
39 | $76 | $112 |
| Destruction of cancer skin growth on trunk, arms, or legs, 0.5 cm or less This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that is 0.5 centimeters or smaller in size. |
35 | $44 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $43 | $56 |
| Shaving of skin growth, 0.5 cm or less Removal of a small skin growth by shaving it off the surface. This procedure is performed on the scalp, neck, hands, feet, or genitals. |
32 | $48 | $69 |
| Shaving of small skin growth on face or mouth area A minor procedure to shave off a small skin growth, measuring 0.5 cm or less, located on the face, ears, eyelids, nose, lips, or mouth. |
32 | $57 | $78 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | 32 | $168 | $228 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $83 | $120 |
| Destruction of skin growth, 15 or more growths | 25 | $91 | $140 |
| Skin growth shaving, 0.5 cm or less This procedure involves shaving off a small skin growth measuring 0.5 centimeters or less from the body, arms, or legs. |
22 | $48 | $76 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface. The procedure is performed on the scalp, neck, hands, feet, or genitals and involves a lesion measuring between 1.1 and 2.0 centimeters. |
20 | $79 | $116 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
19 | $150 | $194 |
| Destruction of cancerous skin growth on face, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 2.1 and 3.0 centimeters in diameter. |
15 | $203 | $263 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
15 | $54 | $77 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,686
Total received (2018-2024)
Avg $241/year across 7 years
Top 40% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
14
Companies
95
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,686 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$150
2023
$216
2022
$141
2021
$239
2020
$108
2019
$388
2018
$445
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$131
Janssen Biotech, Inc.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$904
Amgen Inc.
$230
Mayne Pharma Inc.
$212
Janssen Biotech, Inc.
$57
Ortho Dermatologics, a division of Bausch Health US, LLC
$43
Regeneron Healthcare Solutions, Inc.
$35
KCI USA, Inc.
$31
Taro Pharmaceuticals USA, Inc.
$31
LEO Pharma Inc.
$29
GENZYME CORPORATION
$29
Journey Medical Corporation
$27
Smith+Nephew, Inc.
$22
PruGen, Inc. Pharmaceuticals
$19
Helsinn Therapeutics (U.S.), Inc.
$17
Top 3 companies account for 79.9% of all-time payments
Associated products mentioned in payments ›
0.25% · CIBINQO · Ceracade · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EUCRISA · Exelderm · HALOG OINTMENT (Halcinonide Ointment · Otezla · PREVENA · RENASYS GO v2 HOME · SILIQ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · USP) 0.1% · VALCHLOR
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,275
Per 100K population
40.3
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Radonich is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Radonich experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Radonich performed 3,271 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Radonich receive payments from pharmaceutical companies?
Yes. Dr. Radonich received a total of $1,686 from 14 companies across 95 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Radonich's costs compare to other opticians in Los Alamitos?
Dr. Radonich's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Radonich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Los Alamitos
Browse opticians in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Mayne Pharma Inc. Payments to Doctors
See all physicians who received payments from Mayne Pharma Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology